-
公开(公告)号：US11791657B2
公开(公告)日：2023-10-17
申请号：US17055588
申请日：2019-05-13
发明人： Ziv Rotfogel , Nadav Cohen
CPC分类号： H02J50/001 , A61F2/16 , G02C7/04 , G02C11/10 , H02J7/007 , H02J50/10 , H02J2207/20
摘要： A system for providing electrical energy to an implanted device or to a device attached to a body. The system includes one or more permanent magnets attached to or implanted in a first body part and one or more inductor(s) attached to or implanted in a second body part. The inductor(s) are electrically couplable to the implanted device for providing the implanted device with electrical currents flowing in the one or more inductor(s) in response to changes in the position and/or orientation of the permanent magnet(s) relative to the position and/or orientation of the inductor(s). The system may include a current rectifier for rectifying electrical currents provided by the inductor(s). The system may also include a charge storage device electrically coupled to the current rectifier for storing electrical energy received from the current rectifier.
-
公开(公告)号：US20230390332A1
公开(公告)日：2023-12-07
申请号：US18364319
申请日：2023-08-02
发明人： Ziv Rotfogel , Keren Ben-Yaakov , Michal Simon
摘要： Methods for treatment of cornea epithelium pathologies and conditions, which may benefit from treatment of mitochondrial dysfunction, mitochondrial destruction and/or mitochondrial depletion in the eye, are disclosed. These methods comprise the transplantation of viable exogenous, isolated mitochondria to the cornea, for example, by topical application of designated eyedrops.
-
公开(公告)号：US20220168358A1
公开(公告)日：2022-06-02
申请号：US17594141
申请日：2020-04-03
发明人： Ziv Rotfogel , Keren Ben-Yaakov , Michal Simon
IPC分类号： A61K35/407 , A61P27/02
摘要： Methods for treatment of ocular diseases and conditions associated with mitochondrial dysfunction, mitochondrial destruction and/or mitochondrial depletion in the eye, are disclosed. These methods comprise the transplantation of viable exogenous, isolated mitochondria to ocular tissues. Mitochondrial transplantation is effective in treatment of, e.g., an ocular manifestation of a disease or disorder in a subject, an ophthalmic disease, disorder or condition associated with mitochondrial dysfunction, and/or an ocular ischemic insult in a subject.
-
-
搜索结果
3 条记录 (耗时 0.016 秒)
